Table 2:
Selected Results of the SMART and SALT-ED Trials
| ICU SMART | Non ICU SALT-ED | |||||
|---|---|---|---|---|---|---|
| Components of Primary Outcome |
Balanced Crystalloid % |
Saline % |
% Difference | Balanced Crystalloid % |
Saline % | % Difference |
| In Hospital Death Before 30 Days |
10.3% | 11.1% | 0.8% | 1.4% | 1.5% | 0.1% |
| New RRT | 2.5% | 2.9% | 0.4% | 0.3% | 0.5% | 0.2% |
| Final Serum Creatinine ≥ 200% of Baseline |
6.4% | 6.6% | 0.2% | 3.8% | 4.5% | 0.8% |
|
Major Adverse
Kidney Events within 30 days |
14.3% | 15.4% | 1.1% | 4.7% | 5.6% | 0.9% |